Decreased Androgen Levels and Improved Menstrual Pattern after Angiotensin II Receptor Antagonist Telmisartan Treatment in Four Hypertensive Patients with Polycystic Ovary Syndrome: Case Series

Jensterle, Mojca; Janez, Andrej; Vrtovec, Bojan; Meden-Vrtovec, Helena; Pfeifer, Marija; Prezelj, Janez; Kocjan, Tomaz
December 2007
Croatian Medical Journal;2007, Vol. 48 Issue 6, p864
Academic Journal
No abstract available.


Related Articles

  • Telmisartan: A Viewpoint by H.L. Elliott. Elliott, H.L. // Drugs;Dec1998, Vol. 56 Issue 6, p1045 

    Discusses the use of the angiotensin II receptor antagonist telmisartan in the treatment of cardiovascular disorders. Background on angiotensin II receptor antagonism; Comparison of telmisartan with amlodipine; Features of telmisartan.

  • Telmisartan: A Viewpoint by Wilbert S. Aronow. Aronow, W.S. // Drugs;Dec1998, Vol. 56 Issue 6, p1045 

    Comments on a study on the use of the nonpeptide angiotensin II receptor antagonist telmisartan in the management of hypertension. Details on the dosage and administration of telmisartan; Information on the effectiveness of telmisartan.

  • Telmisartan/hydrochlorothiazide. Verdecchia, Paolo // Drugs;2003, Vol. 63 Issue 19, p2027 

    States that the fixed-dose combination of the angiotensin II receptor antagonist telmisartan and the thiazide diuretic hydrochlorothiazide has the potential to improve the percentage of hypertensive patients with adequately controlled blood pressure. Long duration of action of telmisartan;...

  • Predicting the Success of Metformin Treatment.  // Fertility Weekly;7/1/2002, p11 

    Researchers in Czech Republic identified predictors of improvement in menstrual cyclicity and a decrease in free testosterone index (FTI) in a group of women with polycystic ovary syndrome (PCOS). Insulin resistance may be a key factor in the pathogenesis of PCOS. Therefore, insulin-sensitizing...

  • Telmisartan/Amlodipine: Single-Pill Combination in Hypertension. Moen, Marit D. // American Journal of Cardiovascular Drugs;2010, Vol. 10 Issue 6, p401 

    Telmisartan/amlodipine is a single-pill combination of telmisartan, an angiotensin II receptor antagonist, and amlodipine, a dihydropyridine calcium channel antagonist, which is taken orally once daily for the treatment of hypertension. In the US and the EU, single-pill telmisartan/amlodipine...

  • Telmisartan: A Viewpoint by Norman Sharpe. Sharpe, N. // Drugs;Dec1998, Vol. 56 Issue 6, p1045 

    Discusses the use of the angiotensin II receptor antagonist telmisartan in the management of hypertension and congestive heart failure. Use of angiotensin converting enzyme inhibitors in hypertension; Mechanism of action of angiotensin II receptor antagonist.

  • ANGIOTENSIN II RECEPTOR BLOCKERS: AN OVERVIEW. KHAIRNAR, AMIT K.; BAVISKAR, DHEERAJ T.; JAIN, DINESH K. // International Journal of Pharmacy & Pharmaceutical Sciences;Apr2012 Supplement 3, Vol. 4, p50 

    Blockage of the renin-angiotensin system (RAS) is now recognized as an effective approach to the treatment of hypertension and congestive heart failure. Today, it is possible to antagonize the effects of angiotensin II (AT-II) more specifically by blocking its receptors by using nonpeptide...

  • Telmisartan: A Review of its Use in the Management of Hypertension. Battershill, Anna J.; Scott, Lesley J. // Drugs;2006, Vol. 66 Issue 1, p51 

    Telmisartan (Micardis®, Pritor®), a highly selective angiotensin II (AII) type 1 (AT1) receptor antagonist, is approved for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents. The long elimination half-life of telmisartan ensures the...

  • Efectos clínicos de la metformina en pacientes con síndrome de ovario poliquístico. Galindo G, Carlos G.; Hernández M, Imelda; Ayala, Aquiles R. // Ginecologia y Obstetricia de Mexico;apr2007, Vol. 75 Issue 4, p181 

    Objective: To verify the medical effects of metformin in polycystic ovary syndrome patients. Method: 10 women with polycystic ovary syndrome were including in this prospective clinical study. After a baseline workup, body mass index (BMI) and waist hip index (WHI) were measured; the diagnosis of...

  • A Single Arm Pilot Study of Effects of Berberine on the Menstrual Pattern, Ovulation Rate, Hormonal and Metabolic Profiles in Anovulatory Chinese Women with Polycystic Ovary Syndrome. Li, Lin; Li, Chengyan; Pan, Ping; Chen, Xiaoli; Wu, Xiaoke; Ng, Ernest Hung Yu; Yang, Dongzi // PLoS ONE;12/8/2015, Vol. 10 Issue 12, p1 

    Objective: To evaluate the effects of berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory Chinese women with polycystic ovary syndrome. Methods: Berberine 0.4 g three times per day was given for four months to 102 anovulatory Chinese women with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics